Andreas Peyrl

3.4k total citations
73 papers, 1.2k citations indexed

About

Andreas Peyrl is a scholar working on Genetics, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Andreas Peyrl has authored 73 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Genetics, 23 papers in Molecular Biology and 20 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Andreas Peyrl's work include Glioma Diagnosis and Treatment (37 papers), Brain Metastases and Treatment (16 papers) and Neuroblastoma Research and Treatments (9 papers). Andreas Peyrl is often cited by papers focused on Glioma Diagnosis and Treatment (37 papers), Brain Metastases and Treatment (16 papers) and Neuroblastoma Research and Treatments (9 papers). Andreas Peyrl collaborates with scholars based in Austria, Germany and Switzerland. Andreas Peyrl's co-authors include Irene Slavc, Amedeo A. Azizi, Erwin Hauser, Rainer Seidl, Thomas Czech, Johannes Gojo, Monika Chocholous, Christine Haberler, Gert Lübec and Ulrike Leiss and has published in prestigious journals such as PLoS ONE, Analytical Chemistry and The American Journal of Human Genetics.

In The Last Decade

Andreas Peyrl

67 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andreas Peyrl Austria 21 481 303 286 160 150 73 1.2k
David J. Daniels United States 24 915 1.9× 653 2.2× 518 1.8× 206 1.3× 104 0.7× 154 2.2k
Gerardo Caruso Italy 17 243 0.5× 136 0.4× 280 1.0× 98 0.6× 78 0.5× 73 1.1k
U. Junker Germany 20 861 1.8× 150 0.5× 118 0.4× 76 0.5× 78 0.5× 45 1.8k
Herwig Strik Germany 25 525 1.1× 437 1.4× 213 0.7× 221 1.4× 97 0.6× 73 1.4k
Radhika Iyer United States 20 881 1.8× 86 0.3× 367 1.3× 120 0.8× 122 0.8× 39 1.7k
Bangalore A. Chandramouli India 24 621 1.3× 379 1.3× 256 0.9× 144 0.9× 102 0.7× 54 1.7k
Liliana Viera United States 17 647 1.3× 190 0.6× 342 1.2× 291 1.8× 74 0.5× 34 1.5k
Matthieu Moisse Belgium 23 810 1.7× 148 0.5× 295 1.0× 152 0.9× 93 0.6× 37 1.5k
Joanne Wang United States 21 495 1.0× 110 0.4× 292 1.0× 52 0.3× 157 1.0× 47 1.8k

Countries citing papers authored by Andreas Peyrl

Since Specialization
Citations

This map shows the geographic impact of Andreas Peyrl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Peyrl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Peyrl more than expected).

Fields of papers citing papers by Andreas Peyrl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Peyrl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Peyrl. The network helps show where Andreas Peyrl may publish in the future.

Co-authorship network of co-authors of Andreas Peyrl

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Peyrl. A scholar is included among the top collaborators of Andreas Peyrl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Peyrl. Andreas Peyrl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mayr, Lisa, Amedeo A. Azizi, Johannes Gojo, & Andreas Peyrl. (2025). Medulloblastoma: Current Standard of Care and Future Treatment Opportunities. Pediatric Drugs. 28(1). 31–42.
2.
Mayr, Lisa, Maria T. Schmook, Adalbert Raimann, et al.. (2024). Feasibility and antitumour activity of the FGFR inhibitor erdafitnib in three paediatric CNS tumour patients. Pediatric Blood & Cancer. 71(3). e30836–e30836. 8 indexed citations
3.
Gojo, Johannes, Amedeo A. Azizi, Andreas Peyrl, et al.. (2023). Placement of EVD in pediatric posterior fossa tumors: safe and efficient or old-fashioned? The Vienna experience. Child s Nervous System. 39(8). 2079–2086. 1 indexed citations
4.
Hojreh, Azadeh, Julia Furtner, Christoph Krall, et al.. (2023). Reliability of signal intensity in the basal ganglia on non-contrast T1-weighted MR scans after repetitive application of a gadolinium-based contrast agent in pediatric neuro-oncology patients. European Journal of Radiology. 169. 111179–111179. 2 indexed citations
5.
Czech, Thomas, Andreas Peyrl, Christine Haberler, et al.. (2023). The Site of Origin of Medulloblastoma: Surgical Observations Correlated to Molecular Groups. Cancers. 15(19). 4877–4877. 2 indexed citations
6.
Senfter, Daniel, Julia Furtner, Christine Haberler, et al.. (2023). Proof-of-Concept for Liquid Biopsy Disease Monitoring of MYC-Amplified Group 3 Medulloblastoma by Droplet Digital PCR. Cancers. 15(9). 2525–2525. 8 indexed citations
7.
Pletschko, Thomas, Daniela Prayer, Irene Slavc, et al.. (2023). Initial Evidence for Positive Effects of a Psychological Preparation Program for MRI “iMReady” in Children with Neurofibromatosis Type I and Brain Tumors—How to Meet the Patients’ Needs Best. Journal of Clinical Medicine. 12(5). 1902–1902. 3 indexed citations
8.
Czech, Thomas, Karl Roessler, Anna Cho, et al.. (2022). How can we optimize the long-term outcome in children with intracranial cavernous malformations? A single-center experience of 61 cases. Neurosurgical Review. 45(5). 3299–3313. 3 indexed citations
9.
Leiss, Ulrike, et al.. (2022). Schulische Reintegration von Kindern und Jugendlichen mit einem ZNS-Tumor. Zeitschrift für Neuropsychologie. 33(4). 235–244.
10.
Gojo, Johannes, et al.. (2020). Evaluation and optimization of common lipid extraction methods in cerebrospinal fluid samples. Journal of Chromatography B. 1153. 122271–122271. 16 indexed citations
11.
Lötsch, Daniela, Dominik Kirchhofer, Sushilla van Schoonhoven, et al.. (2019). TERT expression is susceptible to BRAF and ETS-factor inhibition in BRAFV600E/TERT promoter double-mutated glioma. Acta Neuropathologica Communications. 7(1). 128–128. 22 indexed citations
12.
Senfter, Daniel, Robert M. Mader, Johannes Gojo, et al.. (2019). High impact of miRNA-4521 on FOXM1 expression in medulloblastoma. Cell Death and Disease. 10(10). 696–696. 29 indexed citations
13.
Gojo, Johannes, et al.. (2017). Pharmacokinetics of Bevacizumab in Three Patients Under the Age of 3 Years with CNS Malignancies. Drugs in R&D. 17(3). 469–474. 7 indexed citations
14.
Peyrl, Andreas, Josa M. Frischer, Johannes A. Hainfellner, et al.. (2017). Brain tumors – other treatment modalities. Handbook of clinical neurology. 145. 547–560. 1 indexed citations
15.
Azizi, Amedeo A., Ulrike Leiss, Monika Chocholous, et al.. (2017). From Symptom to Diagnosis—The Prediagnostic Symptomatic Interval of Pediatric Central Nervous System Tumors in Austria. Pediatric Neurology. 76. 27–36. 23 indexed citations
16.
Peyrl, Andreas, et al.. (2014). Levetiracetam as a possible cause of secondary graft failure after allogenic hematopoietic stem cell transplantation. European Journal of Paediatric Neurology. 19(1). 75–77. 6 indexed citations
17.
Peyrl, Andreas, Robert Sauermann, Monika Chocholous, et al.. (2013). Pharmacokinetics and Toxicity of Intrathecal Liposomal Cytarabine in Children and Adolescents Following Age-Adapted Dosing. Clinical Pharmacokinetics. 53(2). 165–173. 20 indexed citations
18.
Pasquier, Eddy, Mark W. Kieran, Jaroslav Štěrba, et al.. (2011). Moving Forward with Metronomic Chemotherapy: Meeting Report of the 2nd International Workshop on Metronomic and Anti-Angiogenic Chemotherapy in Paediatric Oncology. Translational Oncology. 4(4). 203–211. 28 indexed citations
19.
Wimmer, Katharina, Irene Slavc, Yael Goldberg, et al.. (2010). Brain tumors in constitutional mismatch repair deficiency syndrome: four new families with biallelic pms2 mutations. Neuro-Oncology. 12(6). 1 indexed citations
20.
Seidl, Rainer, et al.. (2000). A taurine and caffeine-containing drink stimulates cognitive performance and well-being. Amino Acids. 19(3-4). 635–642. 135 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David J. Daniels Breakdown of academic impact, for papers by Gerardo Caruso Breakdown of academic impact, for papers by U. Junker Breakdown of academic impact, for papers by Herwig Strik Breakdown of academic impact, for papers by Radhika Iyer Breakdown of academic impact, for papers by Bangalore A. Chandramouli Breakdown of academic impact, for papers by Liliana Viera Breakdown of academic impact, for papers by Matthieu Moisse Breakdown of academic impact, for papers by Joanne Wang
Rankless by CCL
2026